Institut Gustave Roussy — Villejuif

Public research footprint of Institut Gustave Roussy, compiled from the ClinicalTrials.gov public registry.

1,132

Registered studies

313

Active

176

Recruiting now

560

Completed

175

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Advanced/Metastatic Cervical Cancer · Ovarian Cancer

Recently updated registry entries

NCT07106632 — Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent… (Recruiting)
NCT06772623 — Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab… (Recruiting)
NCT07252232 — Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Institut Gustave Roussy?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.